These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 15516862)

  • 1. Beta blockers as anti-arrhythmic agents.
    Anh D; Marine JE
    Heart Fail Rev; 2004 Apr; 9(2):139-47. PubMed ID: 15516862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug and drug-device therapy in heart failure patients in the post-COMET and SCD-HeFT era.
    Reiffel JA
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S45-58. PubMed ID: 15965572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of beta blockers on morbidity and mortality in heart failure.
    Jafri SM
    Heart Fail Rev; 2004 Apr; 9(2):115-21. PubMed ID: 15516859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta blockers in heart failure.
    Dargie HJ
    Lancet; 2003 Jul; 362(9377):2-3. PubMed ID: 12853188
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-blockers to reduce mortality in patients with systolic dysfunction: a meta-analysis.
    Lee S; Spencer A
    J Fam Pract; 2001 Jun; 50(6):499-504. PubMed ID: 11401736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug therapy of chronic heart failure: when are beta receptor blockers indicated?].
    vom Dahl J; Schotten U; Sasse A
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S48-53. PubMed ID: 10535047
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
    Talbert RL
    Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of carvedilol arrhythmia data in clinical trials.
    Kowey PR
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S59-68. PubMed ID: 15965573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
    Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical pharmacologist's response to Dr Milton Packer's perspective on the results of the COMET trial.
    Shepherd AM
    J Card Fail; 2003 Dec; 9(6):454-7. PubMed ID: 14966784
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta blockers and congestive heart failure.
    Movahed A
    Am Fam Physician; 2000 Dec; 62(11):2402-4. PubMed ID: 11130228
    [No Abstract]   [Full Text] [Related]  

  • 12. COMET: a proposed mechanism of action to explain the results and concerns about dose.
    Coca SG; Buller GK
    Lancet; 2003 Sep; 362(9389):1076; author reply 1077-8. PubMed ID: 14522541
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COMET: a proposed mechanism of action to explain the results and concerns about dose.
    Hjalmarson A; Waagstein F
    Lancet; 2003 Sep; 362(9389):1077; author reply 1077-8. PubMed ID: 14522544
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
    Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol: the new role of beta blockers in congestive heart failure.
    Vanderhoff BT; Ruppel HM; Amsterdam PB
    Am Fam Physician; 1998 Nov; 58(7):1627-34, 1641-2. PubMed ID: 9824960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
    Swedberg K
    Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure.
    Feuerstein G; Ruffolo RR
    Adv Pharmacol; 1998; 42():611-5. PubMed ID: 9327976
    [No Abstract]   [Full Text] [Related]  

  • 19. Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure.
    Ahmed A
    Eur J Heart Fail; 2003 Dec; 5(6):709-15. PubMed ID: 14675848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol for heart failure: renewed interest in beta blockers.
    Young JB
    Cleve Clin J Med; 1997 Sep; 64(8):415-22. PubMed ID: 9308217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.